Assessment of clinical efficacy and safety in a randomized double-blind study of etanercept and sulfasalazine in patients with ankylosing spondylitis from Eastern/Central Europe, Latin America, and Asia
Crossref DOI link: https://doi.org/10.1007/s00296-016-3452-0
Published Online: 2016-03-11
Published Print: 2016-05
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Damjanov, Nemanja
Shehhi, Waleed Al
Huang, Feng
Kotak, Sameer
Burgos-Vargas, Ruben
Shirazy, Khalid
Bananis, Eustratios
Szumski, Annette
Llamado, Lyndon J. Q.
Mahgoub, Ehab
Funding for this research was provided by:
Pfizer
Text and Data Mining valid from 2016-03-11